1261242-10-7

Basic information

• Product Name: benzyl 2-(3-phenylureido)ethylcarbamate
• Synonyms: benzyl 2-(3-phenylureido)ethylcarbamate
• CAS NO: 1261242-10-7
• Molecular Weight: 313.356
• Mol File: 1261242-10-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: benzyl 2-(3-phenylureido)ethylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 2-(3-phenylureido)ethylcarbamate(1261242-10-7)
• EPA Substance Registry System: benzyl 2-(3-phenylureido)ethylcarbamate(1261242-10-7)

Safety Data

• Hazardous Substances Data: 1261242-10-7(Hazardous Substances Data)

Upstream product

• 146552-66-1 benzyl (2-azidoethyl)carbamate 
• 501-53-1 benzyl chloroformate 
• 134307-72-5 2-(((benzyloxy)carbonyl)amino)ethyl 1-methanesulfonate 
• 72080-83-2 2-benzyloxycarbonylaminoethylamine 
• 103-71-9 phenyl isocyanate 
• 77987-49-6 benzyl 2-hydroxyethylcarbamate 

Downstream Products

• 1350454-77-1 1-(2-(4-(6-(3-hydroxyphenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)-3-phenylurea 
• 1350454-74-8 1-(2-(4-(6-(3-methoxyphenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)-3-phenylurea 
• 53673-01-1 1-(2-aminoethyl)-3-phenylurea 
• 1261242-23-2 1-(2-(4-(6-(4-fluorophenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)-3-phenylurea 

Relevant articles and documents

Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies

A series of imidazothiazole derivatives possessing potential activity against melanoma cells were investigated for molecular mechanism of action. The target compounds were tested against V600E-B-RAF and RAF1 kinases. Compound 1zb is the most potent agains

New imidazo[2,1-b]thiazole derivatives: Synthesis, in vitro anticancer evaluation, and in silico studies

A series of 18 new imidazo[2,1-b]thiazole derivatives was synthesized. Their in vitro antiproliferative activities against A375P human melanoma cell line and NCI-60 cell line panel were tested. Compounds 15, 16, 18, 22, 26-28, and 31 showed superior poten